[Nephrogenic diabetes insipidus: Pathogenesis, pathophysiology, and therapy].
Ota
Eriko
E
Department of Nephrology, Tokyo Medical and Dental University.
Sasaki
Sei
S
D051399:Aquaporin 2 / Q000235:genetics / Q000502:physiology; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D018500:Diabetes Insipidus, Nephrogenic / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D018753:Diet, Protein-Restricted; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D009154:Mutation; D017483:Receptors, Vasopressin / Q000235:genetics / Q000502:physiology; D014667:Vasopressins / Q000502:physiology
C496023:AQP2 protein, human; D051399:Aquaporin 2; D052246:Cyclooxygenase 2 Inhibitors; D004232:Diuretics; D017483:Receptors, Vasopressin; D014667:Vasopressins